Occurrence of other tumors in patients with GIST
Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was conf...
Gespeichert in:
Veröffentlicht in: | Surgical oncology 2010-12, Vol.19 (4), p.e140-e143 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e143 |
---|---|
container_issue | 4 |
container_start_page | e140 |
container_title | Surgical oncology |
container_volume | 19 |
creator | Gonçalves, Rinaldo Linhares, Eduardo Albagli, Rafael Valadão, Marcus Vilhena, Bruno Romano, Sérgio Ferreira, Carlos Gil |
description | Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST. |
doi_str_mv | 10.1016/j.suronc.2010.06.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_757464273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0960740410000617</els_id><sourcerecordid>757464273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</originalsourceid><addsrcrecordid>eNqFkU1rGzEQhkVJqB0n_6CUhRx6Wnf0sZL3UiihTQwBH5KcxXo0xnLWK1faTcm_rxa7KeTSk4R4ZvTOM4x94jDnwPXX3TwNMXQ4F5CfQM8B1Ac25QtTl1IKOGNTqDWURoGasIuUdgCgjeAf2UTkS8UFnzJYIQ4xUodUhE0R-i3Foh_2IabCd8Wh6T11fSp--35b3C4fHi_Z-aZpE12dzhl7-vnj8eauvF_dLm--35eolOpL5DVWC1RopEPdOAFOV845mSNpyeu1Alqg1KJGY7QAFG5dKcKcVjQKpJyxL8e-hxh-DZR6u_cJqW2bjsKQrKmM0kqYkbx-R-7CELscznKQVbUAVUOm1JHCGFKKtLGH6PdNfM2QHYXanT0KtaNQC9pmobns86n5sN6Teyv6azAD344AZRkvnqJN6EedzkfC3rrg__fD-wbY-s5j0z7TK6V_s9gkLNiHcanjTjmM--RG_gHgD5qs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035580490</pqid></control><display><type>article</type><title>Occurrence of other tumors in patients with GIST</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</creator><creatorcontrib>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</creatorcontrib><description>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</description><identifier>ISSN: 0960-7404</identifier><identifier>EISSN: 1879-3320</identifier><identifier>DOI: 10.1016/j.suronc.2010.06.004</identifier><identifier>PMID: 20675121</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenocarcinoma ; Adenocarcinoma - epidemiology ; Aged ; Brazil - epidemiology ; Breast cancer ; Child ; Colonic Neoplasms - epidemiology ; Female ; Follow-Up Studies ; Gastrointestinal Stromal Tumors - epidemiology ; Gastrointestinal Stromal Tumors - surgery ; GIST ; Hematology, Oncology and Palliative Medicine ; Humans ; Incidence ; Incidental ; Male ; Mesenchymal ; Metachronous ; Middle Aged ; Mutation ; Neoplasms, Multiple Primary - epidemiology ; Rectal Neoplasms - epidemiology ; Retrospective Studies ; Stomach Neoplasms - epidemiology ; Studies ; Surgery ; Synchronous ; Tumors ; Young Adult</subject><ispartof>Surgical oncology, 2010-12, Vol.19 (4), p.e140-e143</ispartof><rights>Elsevier Ltd</rights><rights>2010 Elsevier Ltd</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</citedby><cites>FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.suronc.2010.06.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20675121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gonçalves, Rinaldo</creatorcontrib><creatorcontrib>Linhares, Eduardo</creatorcontrib><creatorcontrib>Albagli, Rafael</creatorcontrib><creatorcontrib>Valadão, Marcus</creatorcontrib><creatorcontrib>Vilhena, Bruno</creatorcontrib><creatorcontrib>Romano, Sérgio</creatorcontrib><creatorcontrib>Ferreira, Carlos Gil</creatorcontrib><title>Occurrence of other tumors in patients with GIST</title><title>Surgical oncology</title><addtitle>Surg Oncol</addtitle><description>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - epidemiology</subject><subject>Aged</subject><subject>Brazil - epidemiology</subject><subject>Breast cancer</subject><subject>Child</subject><subject>Colonic Neoplasms - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastrointestinal Stromal Tumors - epidemiology</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>GIST</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Incidence</subject><subject>Incidental</subject><subject>Male</subject><subject>Mesenchymal</subject><subject>Metachronous</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasms, Multiple Primary - epidemiology</subject><subject>Rectal Neoplasms - epidemiology</subject><subject>Retrospective Studies</subject><subject>Stomach Neoplasms - epidemiology</subject><subject>Studies</subject><subject>Surgery</subject><subject>Synchronous</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0960-7404</issn><issn>1879-3320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rGzEQhkVJqB0n_6CUhRx6Wnf0sZL3UiihTQwBH5KcxXo0xnLWK1faTcm_rxa7KeTSk4R4ZvTOM4x94jDnwPXX3TwNMXQ4F5CfQM8B1Ac25QtTl1IKOGNTqDWURoGasIuUdgCgjeAf2UTkS8UFnzJYIQ4xUodUhE0R-i3Foh_2IabCd8Wh6T11fSp--35b3C4fHi_Z-aZpE12dzhl7-vnj8eauvF_dLm--35eolOpL5DVWC1RopEPdOAFOV845mSNpyeu1Alqg1KJGY7QAFG5dKcKcVjQKpJyxL8e-hxh-DZR6u_cJqW2bjsKQrKmM0kqYkbx-R-7CELscznKQVbUAVUOm1JHCGFKKtLGH6PdNfM2QHYXanT0KtaNQC9pmobns86n5sN6Teyv6azAD344AZRkvnqJN6EedzkfC3rrg__fD-wbY-s5j0z7TK6V_s9gkLNiHcanjTjmM--RG_gHgD5qs</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Gonçalves, Rinaldo</creator><creator>Linhares, Eduardo</creator><creator>Albagli, Rafael</creator><creator>Valadão, Marcus</creator><creator>Vilhena, Bruno</creator><creator>Romano, Sérgio</creator><creator>Ferreira, Carlos Gil</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Occurrence of other tumors in patients with GIST</title><author>Gonçalves, Rinaldo ; Linhares, Eduardo ; Albagli, Rafael ; Valadão, Marcus ; Vilhena, Bruno ; Romano, Sérgio ; Ferreira, Carlos Gil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-c19c58c4c73dc6ad20d65ddd39606319b40e8c3629c77620c2db54ec7402a4033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - epidemiology</topic><topic>Aged</topic><topic>Brazil - epidemiology</topic><topic>Breast cancer</topic><topic>Child</topic><topic>Colonic Neoplasms - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastrointestinal Stromal Tumors - epidemiology</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>GIST</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Incidence</topic><topic>Incidental</topic><topic>Male</topic><topic>Mesenchymal</topic><topic>Metachronous</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasms, Multiple Primary - epidemiology</topic><topic>Rectal Neoplasms - epidemiology</topic><topic>Retrospective Studies</topic><topic>Stomach Neoplasms - epidemiology</topic><topic>Studies</topic><topic>Surgery</topic><topic>Synchronous</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gonçalves, Rinaldo</creatorcontrib><creatorcontrib>Linhares, Eduardo</creatorcontrib><creatorcontrib>Albagli, Rafael</creatorcontrib><creatorcontrib>Valadão, Marcus</creatorcontrib><creatorcontrib>Vilhena, Bruno</creatorcontrib><creatorcontrib>Romano, Sérgio</creatorcontrib><creatorcontrib>Ferreira, Carlos Gil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gonçalves, Rinaldo</au><au>Linhares, Eduardo</au><au>Albagli, Rafael</au><au>Valadão, Marcus</au><au>Vilhena, Bruno</au><au>Romano, Sérgio</au><au>Ferreira, Carlos Gil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Occurrence of other tumors in patients with GIST</atitle><jtitle>Surgical oncology</jtitle><addtitle>Surg Oncol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>19</volume><issue>4</issue><spage>e140</spage><epage>e143</epage><pages>e140-e143</pages><issn>0960-7404</issn><eissn>1879-3320</eissn><abstract>Abstract Objective Evaluate the presence of other tumors in cohort of patients with GIST treated at a cancer treatment referral center – INCA. Methods We reviewed the medical records of patients diagnosed with GIST who were treated at INCA between 1998 and 2008. Immunohistological diagnosis was confirmed by a pathologist specialized in sarcomas. Patients presenting second non-GIST tumors were identified. Age, sex, tumor location, risk groups (according to the National Institutes of Health criteria), characteristics of non-GIST tumors and treatment results were analyzed. Results Among the 101 patients diagnosed with GIST who were evaluated during the study period, 14 (13.8%) had other non-GIST tumors, 9 females (64.3%), with a median age of 68 years (10–79 years). The stomach was the location of GISTs in 8 cases (57.1%), followed by the small bowel in 4 cases (28.5%), colon and mesentery with 1 case (7.1%) each. The mean size of lesions was 4.79 cm (0.3–15 cm), with malignant potential low/very low in 7 cases (50%), intermediate in 5 cases (35.7%) and high in 2 cases (14.3%). The diagnosis of GIST was incidental in 6 cases and in one case the non-GIST tumor was incidental. The non-GIST tumors were most frequent in the stomach (adenocarcinoma), in 4 cases (28.5%) and colon/rectum (adenocarcinoma) in 4 other cases. The other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma) and adrenal (neuroblastoma), with one case each. The tumors were synchronous in 7 cases (50%). With a median follow-up after GIST resection of 41 months (2–87 months), 9 patients were alive without evidence of disease, 2 died due to GIST, 2 died due to non-GIST tumors and the remaining patient died due to postoperative complications. Conclusions We discovered a 13.8% incidence of non-GIST tumors in a series of 101 GIST cases under our care. This association should always be considered in the management of patients with GIST.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>20675121</pmid><doi>10.1016/j.suronc.2010.06.004</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-7404 |
ispartof | Surgical oncology, 2010-12, Vol.19 (4), p.e140-e143 |
issn | 0960-7404 1879-3320 |
language | eng |
recordid | cdi_proquest_miscellaneous_757464273 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adenocarcinoma Adenocarcinoma - epidemiology Aged Brazil - epidemiology Breast cancer Child Colonic Neoplasms - epidemiology Female Follow-Up Studies Gastrointestinal Stromal Tumors - epidemiology Gastrointestinal Stromal Tumors - surgery GIST Hematology, Oncology and Palliative Medicine Humans Incidence Incidental Male Mesenchymal Metachronous Middle Aged Mutation Neoplasms, Multiple Primary - epidemiology Rectal Neoplasms - epidemiology Retrospective Studies Stomach Neoplasms - epidemiology Studies Surgery Synchronous Tumors Young Adult |
title | Occurrence of other tumors in patients with GIST |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A21%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Occurrence%20of%20other%20tumors%20in%20patients%20with%20GIST&rft.jtitle=Surgical%20oncology&rft.au=Gon%C3%A7alves,%20Rinaldo&rft.date=2010-12-01&rft.volume=19&rft.issue=4&rft.spage=e140&rft.epage=e143&rft.pages=e140-e143&rft.issn=0960-7404&rft.eissn=1879-3320&rft_id=info:doi/10.1016/j.suronc.2010.06.004&rft_dat=%3Cproquest_cross%3E757464273%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035580490&rft_id=info:pmid/20675121&rft_els_id=1_s2_0_S0960740410000617&rfr_iscdi=true |